SCHEMBL26669276

SCHEMBL26669276

C=Cc1cc(S(N)(=O)=O)c(C)nc1Nc1ccc(C(F)(F)F)cn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 5/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ TNNI3K Q59H18 1/20 0.38
▸ POLB P06746 2/20 0.37
▸ KIF11 P52732 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ AR P10275 1/20 0.36
▸ MEN1 O00255 5/20 0.35
▸ KMT2A Q03164 5/20 0.35
▸ CDK5 Q00535 1/20 0.35
▸ CDK5R1 Q15078 1/20 0.35
▸ MAPK10 P53779 1/20 0.35
▸ TRPV1 Q8NER1 1/20 0.35
▸ XPO1 O14980 1/20 0.35
▸ MAPT P10636 4/20 0.35
▸ NPY5R Q15761 1/20 0.35
▸ PTGS1 P23219 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ AGTR1 P30556 1/20 0.34
▸ RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26669331 0.85 CA1 (0.42) KIF11LMNAARTRPV1MAPT
SCHEMBL26669264 0.79 GAA (0.44) GAAKDM4ETNNI3KPOLBKIF11
SCHEMBL29704107 0.75 MAPK10 (0.41) GAAKDM4ETNNI3KPOLBKIF11
SCHEMBL29704110 0.75 MAPK10 (0.41) GAAKDM4ETNNI3KPOLBKIF11
SCHEMBL24497432 0.74 MAPT (0.53) GAAKDM4ETNNI3KPOLBMEN1
SCHEMBL29648339 0.74 MAPT (0.53) GAAKDM4ETNNI3KPOLBMEN1
SCHEMBL22718342 0.72 KDM4E (0.54) GAAKDM4ETNNI3KPOLBKIF11
SCHEMBL29704094 0.72 KDM4E (0.54) GAAKDM4ETNNI3KPOLBKIF11
SCHEMBL30194891 0.69 PTGES2 (0.54) GAAKDM4ETNNI3KLMNAAR
SCHEMBL29648442 0.68 TNNI3K (0.55) GAAKDM4ETNNI3KMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4281073-A1 COMBINATION OF A 3-(IMIDAZOL-4-YL)-4-(AMINO)-BENZENESULFONAMIDE TEAD INHIBITOR WITH AN EGFR INHIBITOR AND/OR MEK INHIBITOR FOR USE IN THE TREATMENT OF LUNG CANCER Ikena Oncology, Inc. (US) 2023-11-29 — — EP disclosed
WO-2022159986-A1 COMBINATION OF A 3-(IMIDAZOL-4-YL)-4-(AMINO)-BENZENESULFONAMIDE TEAD INHIBITOR WITH AN EGFR INHIBITOR AND/OR MEK INHIBITOR FOR USE IN THE TREATMENT OF LUNG CANCER Ikena Oncology, Inc. (US) 2022-07-28 — — WO disclosed
Send feedback